Spider Rock Advisors, LLC Biogen Inc. Call Options Transaction History

Spider Rock Advisors, LLC

  • $6.17 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2019

Jul 29, 2019
SELL
$219.29 - $241.72 $460,509 - $507,612
-2,100 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$216.71 - $338.96 $455,091 - $711,816
2,100 New
2,100 $2,000
Q4 2017

Feb 14, 2018
SELL
$307.64 - $344.58 $2.46 Million - $2.76 Million
-8,000 Closed
0 $0
Q3 2017

Oct 18, 2017
BUY
$281.15 - $329.69 $2.25 Million - $2.64 Million
8,000
8,000 $187,000

Others Institutions Holding BIIB

# of Institutions
998
Shares Held
130M
Call Options Held
1.12M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $20.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Spider Rock Advisors, LLC Portfolio

Follow Spider Rock Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spider Rock Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spider Rock Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email